CRWD:NASDAQCrowdStrike Holdings, Inc. Analysis
Data as of 2026-05-25 - not real-time
$663.46
Latest Price
8/10Risk
Risk Level: High
Executive Summary
CrowdStrike is trading at a level just below its recent resistance, with volume accelerating and a bullish MACD histogram confirming upward momentum. Technical indicators such as an RSI well above the 70 threshold and a high 30‑day volatility reading point to an overbought, high‑risk environment, while the beta of roughly 1.3 signals greater sensitivity to market swings.
Fundamentally, the company delivers robust top‑line growth – over 23% year‑over‑year revenue expansion and a $5.25B annual recurring revenue base – yet it remains unprofitable, posting negative earnings per share and a sizeable max drawdown exceeding 35% of its market cap.
The market’s pricing multiples (forward P/E above 100×, price‑to‑book near 38×, and price‑to‑sales beyond 35×) together with an “Extreme Greed” sentiment index suggest the stock is priced at a premium that may not be fully justified by current cash flow generation.
Fundamentally, the company delivers robust top‑line growth – over 23% year‑over‑year revenue expansion and a $5.25B annual recurring revenue base – yet it remains unprofitable, posting negative earnings per share and a sizeable max drawdown exceeding 35% of its market cap.
The market’s pricing multiples (forward P/E above 100×, price‑to‑book near 38×, and price‑to‑sales beyond 35×) together with an “Extreme Greed” sentiment index suggest the stock is priced at a premium that may not be fully justified by current cash flow generation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- overbought RSI reading
- price proximity to recent resistance
- elevated short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- 23% YoY revenue growth
- integration of Anthropic’s Claude Opus AI model
- forward P/E expectations of earnings acceleration
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- strong ARR trajectory and market leadership in cloud‑based cybersecurity
- expanding AI‑driven product suite
- robust cash position despite high leverage
Key Metrics & Analysis
Financial Health
Revenue Growth23.30%
Profit Margin-3.38%
P/E Ratio107.7
ROE-4.14%
ROA-1.57%
Debt/Equity18.34
P/B Ratio38.0
Op. Cash Flow$1.6B
Free Cash Flow$1.6B
Industry P/E39.5
Technical Analysis
TrendNeutral
RSI86.9
Support$432.55
Resistance$674.84
MA 20$536.66
MA 50$462.83
MA 200$465.21
MACDBullish
VolumeIncreasing
Fear & Greed Index91.8
Valuation
Fair Value$227.79
Target Price$535.33
Upside/Downside-19.31%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.35
Volatility39.98%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.